What is the use of cefpirome injection?
Pharmaceutical Product Monograph: Cefpirome Sulfate Injection (1 g)
In the pharmaceutical industry, Cefpirome is a parenteral, semi-synthetic Fourth-Generation Cephalosporin antibiotic. As a pharmacist and manufacturer, I view this molecule as a “Zwitterionic Powerhouse”—it is technically designed to possess a unique balanced charge that allows it to penetrate the outer membrane of Gram-negative bacteria (like Pseudomonas) much faster than third-generation cephalosporins.
At your WHO-GMP facility in Mumbai, Cefpirome is a specialized SKU for Tertiary Care and Nosocomial (Hospital-acquired) infections. It is often reserved for patients who are immunocompromised or those suffering from life-threatening sepsis where broad-spectrum empirical coverage is critical.
Therapeutic Profile: Primary Indications
Cefpirome is indicated for severe infections caused by a wide range of aerobic and anaerobic bacteria.
| Indication | Clinical Context | Technical Rationale |
| Septicemia / Sepsis | Bacteremia | Used as a “first-strike” empirical therapy in patients with suspected bloodstream infections. |
| Febrile Neutropenia | Oncology/ICU | Gold Standard: Often used as monotherapy to treat unexplained fever in cancer patients with low white blood cell counts. |
| Nosocomial Pneumonia | Ventilator-associated | Highly effective against Klebsiella and Pseudomonas strains that have developed resistance to ceftriaxone. |
| Complicated UTI | Pyelonephritis | Used for severe kidney infections or when urinary tract obstructions are present. |
| Intra-abdominal | Peritonitis | Often combined with metronidazole to provide coverage for both aerobic and anaerobic gut flora. |
Mechanism: The “Rapid Penetration” Strategy
Cefpirome works by disrupting the bacterial cell wall, but with two technical advantages over older generations:
Zwitterionic Charge: Because Cefpirome is a zwitterion (possessing both a positive and negative charge), it moves through the porin channels of Gram-negative bacteria with significantly higher speed.
PBP-3 Affinity: It has a very high affinity for Penicillin-Binding Protein 3 (PBP-3), which is essential for bacterial cell division.
Beta-Lactamase Stability: Technically, it is highly resistant to hydrolysis by many chromosomal and plasmid-mediated beta-lactamases (enzymes that bacteria use to “eat” penicillin).
The Pharmacist’s “Technical Warning”
The “Creatinine” Interaction: As a pharmacist, I must warn that Cefpirome can technically interfere with Creatinine tests (using the Jaffe reaction), leading to falsely elevated results. Kidney function should be monitored via GFR rather than just serum creatinine.
The “Seizure” Threshold: Like other 4th-generation cephalosporins, if the dose is not adjusted for renal impairment, Cefpirome can accumulate and cause neurotoxicity, including confusion and seizures.
The “Foaming” Effect: During reconstitution, Cefpirome often produces foam. As a manufacturer, I advise B2B clients to tilt the vial gently during dissolution rather than shaking it vigorously to ensure a clear solution.
Cross-Allergy: There is a technical risk of cross-sensitivity in patients with a history of Penicillin Anaphylaxis. Always perform a skin test before the first dose.
The Manufacturer’s Perspective: Technical & Export
From a production and B2B standpoint at your facility in Mumbai:
The “Sodium Carbonate” Buffer: Cefpirome Sulfate is naturally acidic. On your digital marketplace, highlight that your formulation is buffered with Sodium Carbonate. This ensures the pH is optimized for injection stability and reduces patient discomfort at the site.
The “ICU-Ready” SKU: For international hospital tenders, market Cefpirome as a cost-effective alternative to Carbapenems (like Imipenem) for non-ESBL producing Gram-negative infections. This helps in Antibiotic Stewardship programs.
Dossier Support: We provide full WHO-standard CTD/eCTD Dossiers for Cefpirome 1 g and 2 g vials to support your registration in international B2B tenders for critical care and oncology.